Leading companies are revamping research and early development to curb lengthy drug development timelines and rising costs. Source: McKinsey Operational excellence in biopharma research and early development
A modern, well-designed tech stack can unlock the potential of AI, automation, and data and their promised benefits to R&D productivity. Source: McKinsey Boosting biopharma R&D performance with a next-generation technology stack
Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent. What R&D skills do they need today, and how can they sustain this workforce? Source: McKinsey Putting people at the center of the R&D talent model in life sciences
Wharton experts speak with Bill Connelly, staff writer at ESPN.…Read More Source: Knowledge @ Wharton College Football Playoffs with Bill Connelly
Howard Jacob, vice president of genomics research and head of data integration at AbbVie, shares his view on the potential of personalized data, AI, and machine learning to prevent and cure disease. Source: McKinsey AbbVie’s head of genomics research on the transformative power of AI
Challenging times in agriculture have reinforced the importance of productivity for profitability, a McKinsey survey of Brazilian farmers found. Source: McKinsey Why Brazilian farmers are doubling down on productivity
Connections, contexts, and capabilities can guide corporate efforts to create empowerment impact efficiently. Source: McKinsey Economic empowerment made-to-measure: How companies can benefit more people
Wharton real estate professor joins the show to review the real estate market in 2024 and what to expect in 2025.…Read More Source: Knowledge @ Wharton The Real Estate Market Survived Until 2025. What’s Next?
Wharton’s Lynn Wu predicts that the runaway growth of artificial intelligence will hit some roadblocks in 2025, including cost and data limitation.…Read More Source: Knowledge @ Wharton AI in 2025: What Challenges Lie Ahead?
The coming year could see tech stocks cooling off and very modest rate cuts by the Federal Reserve, Wharton’s Jeremy Siegel predicts.…Read More Source: Knowledge @ Wharton Jeremy Siegel: 2025 Outlook for Stocks and the Economy